Clinical Trials for iOnctura

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: iOnctura

Clinical Trials (6)

NCT07018752
A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas
PHASE1/PHASE2Not yet recruiting
49 participants
Started: Aug 31, 2025 · Completed: Jan 31, 2030
1 condition4 sponsors20 locations
NCT06887803
A Study of Roginolisib in Combination With Ruxolitinib in Patients With Myelofibrosis (MF) Who Are Unresponsive to JAK Inhibitors
PHASE1/PHASE2Recruiting
26 participants
Started: May 31, 2025 · Completed: Jul 31, 2028
1 condition1 sponsor3 locations
NCT06879717
A Study of Roginolisib (IOA-244) in Combination With Dostarlimab With or Without Docetaxel in Metastatic Non Small-cell Lung Cancer (NSCLC) Patients
PHASE1/PHASE2Recruiting
45 participants
Started: Apr 22, 2025 · Completed: Jan 31, 2028
2 conditions1 sponsor7 locations
NCT06717126
A Randomised Phase II Study of Roginolisib in Patients With Advanced/Metastatic Uveal Melanoma
PHASE2Recruiting
85 participants
Started: Feb 27, 2025 · Completed: Dec 31, 2028
2 conditions1 sponsor16 locations
NCT05586516
A Study to Assess an ATX Inhibitor (IOA-289) in Patients with Metastatic Pancreatic Cancer
PHASE1/PHASE2Active, not recruiting
24 participants
Started: Oct 10, 2022 · Completed: Mar 1, 2026
1 condition1 sponsor3 locations
NCT04328844
A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers
PHASE1Active, not recruiting
210 participants
Started: Feb 25, 2020 · Completed: Mar 31, 2025
5 conditions1 sponsor3 locations